Intrinsiqs

Is Eton Pharmaceuticals, Inc. overvalued?

Eton Pharmaceuticals, Inc. (ETON) — key valuation metrics and fundamentals.

No verdict
Price
$63.93
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$1.84B
Dividend yield
0.0%
Return on equity
104.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ETON's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.